These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27453120)

  • 41. Breast cancer screening: a dividing controversy.
    Khrouf S; Letaief Ksontini F; Ayadi M; Belhaj Ali Rais H; Mezlini A
    Tunis Med; 2020 Jan; 98(1):22-34. PubMed ID: 32395774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Why mammography screening has not lived up to expectations from the randomised trials.
    Gøtzsche PC; Jørgensen KJ; Zahl PH; Mæhlen J
    Cancer Causes Control; 2012 Jan; 23(1):15-21. PubMed ID: 22072221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of extending screening mammography to older women: Information to support informed choices.
    Jacklyn G; Howard K; Irwig L; Houssami N; Hersch J; Barratt A
    Int J Cancer; 2017 Oct; 141(8):1540-1550. PubMed ID: 28662267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
    Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
    Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overdiagnosis of screen-detected breast cancer.
    Milch V; Aranda S; Canfell K; Varlow M; Roder DM; Currow D; Anderiesz C; Keefe D
    Med J Aust; 2021 Jun; 214(10):455-456.e1. PubMed ID: 33993477
    [No Abstract]   [Full Text] [Related]  

  • 47. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
    Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
    Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mammography-detected ultrasound-negative asymptomatic micro-calcifications in Chinese women: Would it be safe to watch and wait?
    Xu Y; Pan B; Zhou YD; Yao R; Zhu QL; Zhang J; Mao F; Lin Y; Shen SJ; Sun Q
    Med Hypotheses; 2018 Sep; 118():9-12. PubMed ID: 30037622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

  • 51. Screening for Breast Cancer in Women Age 75 Years and Older.
    Lee CS; Moy L; Joe BN; Sickles EA; Niell BL
    AJR Am J Roentgenol; 2018 Feb; 210(2):256-263. PubMed ID: 29112471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Screening for breast cancer: worries about its effectiveness].
    Autier P
    Rev Prat; 2013 Dec; 63(10):1369-77. PubMed ID: 24579331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer mortality in Norway after the introduction of mammography screening.
    Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
    Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast Cancer Screening Trials: Endpoints and Overdiagnosis.
    Jatoi I; Pinsky PF
    J Natl Cancer Inst; 2021 Sep; 113(9):1131-1135. PubMed ID: 32898241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
    Bluekens AM; Holland R; Karssemeijer N; Broeders MJ; den Heeten GJ
    Radiology; 2012 Dec; 265(3):707-14. PubMed ID: 23033499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 58. [DIFFERENT APPROACHES TO MAMMOGRAPHY AS A SCREENING TOOL FOR BREAST CANCER].
    Melnik I; Rapson Y; Gropstein A; Sharon E
    Harefuah; 2022 Feb; 161(2):121-124. PubMed ID: 35195975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early evaluation of an organised mammography screening program in Greece 2004-2009.
    Simou E; Tsimitselis D; Tsopanlioti M; Anastasakis I; Papatheodorou D; Kourlaba G; Gerasimos P; Maniadakis N
    Cancer Epidemiol; 2011 Aug; 35(4):375-80. PubMed ID: 21474412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.